JUN 01, 2021 3:32 PM PDT

Can Cannabis Help Manage Symptoms of Multiple Sclerosis?

WRITTEN BY: Annie Lennon

As laws around cannabinoids continue to evolve, some people with chronic illnesses such as multiple sclerosis (MS), are using cannabis to reduce their symptoms. But is cannabis effective in managing symptoms of MS? 

MS is a chronic disease that affects the central nervous system. While its cause is unknown, the disease is characterized by the immune system attacking nerve fibers and myelin sheaths (a fatty substance surrounding nerve fibers that aids their communications) in the brain and spinal cord. This can lead to fatigue and numbness, or in more severe cases, vision loss, paralysis and diminished brain function. 

Most research that has examined the effects of cannabis on MS involves cannabis in the form of an oromucosal spray known as Sativex that contains both THC and CBD. A summary from 2014 for example found that the spray may be effective against spasticity symptoms, pain and urinary frequency among those with MS. The researchers noted however that it has little efficacy for tremors. 

Another study from 2018 found that cannabis products on a 1:1 ratio of CBD to THC may be able to lessen muscle spasticity and pain among people with MS. The study also found that cannabis may reduce inflammation related to fatigue. This, according to the researchers, could also improve mobility among those with MS. 

Meanwhile, a study also from 2018, found that Sativex use among those with MS was not associated with a higher incidence of motor vehicle accidents. In fact, the study found that the majority of patients using the medicine noticed an improvement in their driving ability after using the spray. The researchers noted that this may have come due to reduced spasticity and/ or better cognitive function resulting from the spray. 

While there seem to be some benefits of using cannabis for symptoms of MS, further research is needed to confirm its therapeutic effects, as well as its safety for those with the condition. Nevertheless, the National MS Society advocates for the legalization of cannabis at the state level and seeks to remove federal barriers towards researching the substance. 

 

Sources: HealthlinePubMed

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUN 15, 2022
Cannabis Sciences
Cannabis and intimacy
JUN 15, 2022
Cannabis and intimacy
Does cannabis enhance or inhibit intimacy? The answer is complicated
JUL 07, 2022
Cannabis Sciences
HHC, the latest cannabinoid
JUL 07, 2022
HHC, the latest cannabinoid
What is HHC? Read on to learn about the latest cannabinoid
JUL 15, 2022
Cannabis Sciences
What THC and CBD Really Taste Like
JUL 15, 2022
What THC and CBD Really Taste Like
Do THC and CBD have any kind of taste? What is it like?
AUG 04, 2022
Cannabis Sciences
Don't Smoke the Reclaim. Here's Why.
AUG 04, 2022
Don't Smoke the Reclaim. Here's Why.
Here's what reclaim is, why you should leave it alone, and what you should do with it instead.
SEP 07, 2022
Health & Medicine
Patient Preferences Include a Diverse Range of Cannabis Products
SEP 07, 2022
Patient Preferences Include a Diverse Range of Cannabis Products
An analysis of point-of-sale data from nearly 17,000 New York medical cannabis patients revealed significant product var ...
NOV 17, 2022
Cannabis Sciences
Medical Cannabis Patients Feel Validated by Changes in Cannabis Stigma and Policy
NOV 17, 2022
Medical Cannabis Patients Feel Validated by Changes in Cannabis Stigma and Policy
Drexel University researchers examined the effects of California’s 2016 recreational cannabis use law among young ...
Loading Comments...